Paul Wender
Academic Appointments
- Professor, Natural Sciences Cluster - Chemistry
- Member, Bio-X
- Member, Stanford Cancer Institute
- Professor (By courtesy), Chemical and Systems Biology
Key Documents
Contact Information
- Academic Offices
Personal Information Email Tel (650) 723-0208 Tel (650) 723-3898
Professional Overview
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Publications
- "Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivo. Oncotarget. 2012; (1): 58-66
- Beyond Cell Penetrating Peptides: Designed Molecular Transporters. Drug Discov Today Technol. 2012; (1): e49-e55
- Designed guanidinium-rich amphipathic oligocarbonate molecular transporters complex, deliver and release siRNA in cells. Proc Natl Acad Sci U S A. 2012; (33): 13171-6
- Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro. Nat Chem. 2012; (9): 705-10
- Rhodium dinaphthocyclooctatetraene complexes: synthesis, characterization and catalytic activity in [5+2] cycloadditions. Angew Chem Int Ed Engl. 2012; (11): 2736-40
- Taxol-oligoarginine conjugates overcome drug resistance in-vitro in human ovarian carcinoma. Gynecol Oncol. 2012; (1): 118-23
Help
Trial Administration